271 related articles for article (PubMed ID: 2902264)
1. Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects.
Whittle H; Hanlon P; O'Neill K; Hanlon L; Marsh V; Jupp E; Aaby P
Lancet; 1988 Oct; 2(8615):811-4. PubMed ID: 2902264
[TBL] [Abstract][Full Text] [Related]
2. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.
Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA
Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572
[TBL] [Abstract][Full Text] [Related]
3. Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine.
Whittle HC; Campbell H; Rahman S; Armstrong JR
Lancet; 1990 Oct; 336(8722):1046-8. PubMed ID: 1977029
[TBL] [Abstract][Full Text] [Related]
4. Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy.
Aaby P; Jensen TG; Hansen HL; Kristiansen H; Thårup J; Poulsen A; Sodemann M; Jakobsen M; Knudsen K; Clotilde da Silva M
Lancet; 1988 Oct; 2(8615):809-11. PubMed ID: 2902263
[TBL] [Abstract][Full Text] [Related]
5. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH
N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505
[TBL] [Abstract][Full Text] [Related]
6. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine.
Garly ML; Balé C; Martins CL; Monteiro M; George E; Kidd M; Dias F; Aaby P; Whittle HC
Vaccine; 2001 Feb; 19(15-16):1951-9. PubMed ID: 11228365
[TBL] [Abstract][Full Text] [Related]
7. Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.
Martins C; Garly ML; Bale C; Rodrigues A; Benn CS; Whittle H; Aaby P
Vaccine; 2013 Nov; 31(48):5766-71. PubMed ID: 23994379
[TBL] [Abstract][Full Text] [Related]
8. Measles control in Kinshasa, Zaire improved with high coverage and use of medium titre Edmonston Zagreb vaccine at age 6 months.
Cutts FT; Othepa O; Vernon AA; Nyandu B; Markowitz LE; Deforest A; Wilkins K; Okwo B
Int J Epidemiol; 1994 Jun; 23(3):624-31. PubMed ID: 7960392
[TBL] [Abstract][Full Text] [Related]
9. Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal.
Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Whittle H
Am J Epidemiol; 1993 Nov; 138(9):746-55. PubMed ID: 8237989
[TBL] [Abstract][Full Text] [Related]
10. Child mortality following standard, medium or high titre measles immunization in West Africa.
Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
[TBL] [Abstract][Full Text] [Related]
11. Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months.
Tidjani O; Grunitsky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
Lancet; 1989 Dec; 2(8676):1357-60. PubMed ID: 2574304
[TBL] [Abstract][Full Text] [Related]
12. Trials of Edmonston-Zagreb measles vaccine in Guinea-Bissau: serological responses following vaccination with Edmonston-Zagreb strain at 4-8 months versus vaccination with Schwarz strain at 9-12 months of age.
Jensen TG; Whittle H; Mordhorst CH; Pedersen IR; Thaarup J; Poulsen A; Sodemann M; Jakobsen M; Brink L; Gansted U
Vaccine; 1994 Aug; 12(11):1026-31. PubMed ID: 7975843
[TBL] [Abstract][Full Text] [Related]
13. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
[TBL] [Abstract][Full Text] [Related]
14. [Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months].
Tidjani O; Grunitzky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):873-84. PubMed ID: 1819435
[TBL] [Abstract][Full Text] [Related]
15. Expanded programme on immunization (EPI). Safety of high titre measles vaccines.
Wkly Epidemiol Rec; 1992 Nov; 67(48):357-61. PubMed ID: 1449986
[TBL] [Abstract][Full Text] [Related]
16. Successful immunization of infants at 6 months of age with high dose Edmonston-Zagreb measles vaccine. Cite Soleil/JHU Project Team.
Job JS; Halsey NA; Boulos R; Holt E; Farrell D; Albrecht P; Brutus JR; Adrien M; Andre J; Chan E
Pediatr Infect Dis J; 1991 Apr; 10(4):303-11. PubMed ID: 2062626
[TBL] [Abstract][Full Text] [Related]
17. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
[TBL] [Abstract][Full Text] [Related]
18. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial.
Dilraj A; Cutts FT; de Castro JF; Wheeler JG; Brown D; Roth C; Coovadia HM; Bennett JV
Lancet; 2000 Mar; 355(9206):798-803. PubMed ID: 10711928
[TBL] [Abstract][Full Text] [Related]
19. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
Dilraj A; Sukhoo R; Cutts FT; Bennett JV
Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
[TBL] [Abstract][Full Text] [Related]
20. Immunization of young infants with Edmonston-Zagreb measles vaccine.
Markowitz LE; Bernier RH
Pediatr Infect Dis J; 1987 Sep; 6(9):809-12. PubMed ID: 3313247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
